FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945394975> ?p ?o ?g. }

• W2945394975 endingPage "3904" @default.
• W2945394975 startingPage "3892" @default.
• W2945394975 abstract "Abstract Background Natural Killer T–Cell Lymphoma (NKTCL) is a subtype of Non‐Hodgkin's Lymphoma, and its morbidity is ranked the first of T‐Cell Lymphoma. Hippo signaling pathway is involved in the pathogenesis of tumors. However, the role of Hippo signaling pathway in the oncogenesis of NKTCL still remains unclear. Methods The expressions of mammalian sterile 20‐like kinase 1 (MST1) and Yes‐associated protein (YAP) were investigated by RT‐PCR and Western blotting. Cell viability was detected by MTT assays. Cell cycle and cell apoptosis were determined by flow cytometry. Cell proliferative capacity was detected by colony formation assay. Nude mice xenograft models were established and the tumor sections were analyzed by immunohistochemistry (IHC) staining. Results The expression of MST1 was significantly down‐regulated in NKTCL tissues (n = 30) and cell lines, while the expression of YAP was significantly up‐regulated, and the phosphorylation of YAP was inhibited. Overexpression of MST1, knockdown of YAP, or verteporfin (VP) treatment could inhibit cell proliferation, and promote cell cycle arrest and apoptosis in NKTCL cells, while knockdown of MST1 and overexpression of YAP promoted cell proliferation. Additionally, Bcl‐2/Bax ratio and downstream effectors of Hippo signaling pathway (c‐myc, survivin, cyclinD1, CTGF, and TEAD) were significantly decreased when MST1 was overexpressed and YAP was knocked down or after VP treatment. Furthermore, our mice model demonstrated that activation of Hippo signal pathway suppressed the tumorigenesis of NKTCL. Conclusion The activation of Hippo signal pathway via overexpressing MST1 or down‐regulating YAP can inhibit the tumorigenesis of NKTCL." @default.
• W2945394975 created "2019-05-29" @default.
• W2945394975 creator A5007823796 @default.
• W2945394975 creator A5010480280 @default.
• W2945394975 creator A5019544133 @default.
• W2945394975 creator A5022526821 @default.
• W2945394975 creator A5029441253 @default.
• W2945394975 creator A5044104650 @default.
• W2945394975 creator A5046621948 @default.
• W2945394975 creator A5048995364 @default.
• W2945394975 creator A5056422120 @default.
• W2945394975 creator A5069036111 @default.
• W2945394975 creator A5072036342 @default.
• W2945394975 creator A5072861069 @default.
• W2945394975 creator A5080214203 @default.
• W2945394975 creator A5083087794 @default.
• W2945394975 creator A5089378544 @default.
• W2945394975 date "2019-05-23" @default.
• W2945394975 modified "2023-10-18" @default.
• W2945394975 title "Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells" @default.
• W2945394975 cites W1063509641 @default.
• W2945394975 cites W1521137839 @default.
• W2945394975 cites W1963272969 @default.
• W2945394975 cites W1963927300 @default.
• W2945394975 cites W1968910405 @default.
• W2945394975 cites W1977198374 @default.
• W2945394975 cites W1992276490 @default.
• W2945394975 cites W1992294689 @default.
• W2945394975 cites W2004480757 @default.
• W2945394975 cites W2006778392 @default.
• W2945394975 cites W2015150577 @default.
• W2945394975 cites W2016672123 @default.
• W2945394975 cites W2020045401 @default.
• W2945394975 cites W2031721011 @default.
• W2945394975 cites W2032853143 @default.
• W2945394975 cites W2036632714 @default.
• W2945394975 cites W2037072072 @default.
• W2945394975 cites W2060073863 @default.
• W2945394975 cites W2074230122 @default.
• W2945394975 cites W2083121410 @default.
• W2945394975 cites W2090168356 @default.
• W2945394975 cites W2097069901 @default.
• W2945394975 cites W2100641053 @default.
• W2945394975 cites W2105193974 @default.
• W2945394975 cites W2111172225 @default.
• W2945394975 cites W2112413714 @default.
• W2945394975 cites W2113282595 @default.
• W2945394975 cites W2140856397 @default.
• W2945394975 cites W2141595533 @default.
• W2945394975 cites W2148008686 @default.
• W2945394975 cites W2148056172 @default.
• W2945394975 cites W2150294095 @default.
• W2945394975 cites W2160289258 @default.
• W2945394975 cites W2162103488 @default.
• W2945394975 cites W2171501785 @default.
• W2945394975 cites W2216321393 @default.
• W2945394975 cites W2297410491 @default.
• W2945394975 cites W2561879836 @default.
• W2945394975 cites W2606016578 @default.
• W2945394975 cites W2892093839 @default.
• W2945394975 cites W977201031 @default.
• W2945394975 doi "https://doi.org/10.1002/cam4.2174" @default.
• W2945394975 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6639190" @default.
• W2945394975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31124291" @default.
• W2945394975 hasPublicationYear "2019" @default.
• W2945394975 type Work @default.
• W2945394975 sameAs 2945394975 @default.
• W2945394975 citedByCount "20" @default.
• W2945394975 countsByYear W29453949752020 @default.
• W2945394975 countsByYear W29453949752021 @default.
• W2945394975 countsByYear W29453949752022 @default.
• W2945394975 countsByYear W29453949752023 @default.
• W2945394975 crossrefType "journal-article" @default.
• W2945394975 hasAuthorship W2945394975A5007823796 @default.
• W2945394975 hasAuthorship W2945394975A5010480280 @default.
• W2945394975 hasAuthorship W2945394975A5019544133 @default.
• W2945394975 hasAuthorship W2945394975A5022526821 @default.
• W2945394975 hasAuthorship W2945394975A5029441253 @default.
• W2945394975 hasAuthorship W2945394975A5044104650 @default.
• W2945394975 hasAuthorship W2945394975A5046621948 @default.
• W2945394975 hasAuthorship W2945394975A5048995364 @default.
• W2945394975 hasAuthorship W2945394975A5056422120 @default.
• W2945394975 hasAuthorship W2945394975A5069036111 @default.
• W2945394975 hasAuthorship W2945394975A5072036342 @default.
• W2945394975 hasAuthorship W2945394975A5072861069 @default.
• W2945394975 hasAuthorship W2945394975A5080214203 @default.
• W2945394975 hasAuthorship W2945394975A5083087794 @default.
• W2945394975 hasAuthorship W2945394975A5089378544 @default.
• W2945394975 hasBestOaLocation W29453949751 @default.
• W2945394975 hasConcept C121608353 @default.
• W2945394975 hasConcept C1491633281 @default.
• W2945394975 hasConcept C153911025 @default.
• W2945394975 hasConcept C172512520 @default.
• W2945394975 hasConcept C173396325 @default.
• W2945394975 hasConcept C190283241 @default.
• W2945394975 hasConcept C2775975398 @default.
• W2945394975 hasConcept C29537977 @default.
• W2945394975 hasConcept C502942594 @default.

• next